January, 11 2021, 11:00pm EDT
Drug Company Insider Stock Dumping Surged as Taxpayer-Funded Vaccines Moved Toward Approval
WASHINGTON
Today, Accountable Pharma released a new report outlining the more than $250 million in insider stock sales by executives and directors at five major drug companies producing vaccines with taxpayer support, including $105 million in new profits from insider sales between September and mid-November.
"Drug company executives continue shamelessly shoveling eye-popping amounts of money into their pockets after pumping share prices up with announcements that would have never been possible without taxpayer investments," said Eli Zupnick, spokesman for Accountable Pharma. "The Trump Administration should have included clear anti-profiteering provisions in the contracts handing billions of dollars to these drug companies, but since they didn't, we are calling on the companies to freeze all insider stock sales until the SEC can investigate their legality and propriety."
This new report builds on a previous report from Accountable Pharma that compiled executive trading data from the launch of Operation Warp Speed on May 15 through August 31, 2020 and found they made stock transactions valued at a net profit of more than $145 million.
On November 17th, SEC Chairman Jay Clayton called on drug companies to enact a "cooling off period" on their insider stock sale plans and make other changes to avoid potential insider trading and make sure companies are acting with "transparency and rigorous governance." Accountable Pharma has called for an SEC investigation and for freezes on insider stock sales at Moderna and Pfizer to prevent the kind of insider profiteering off of initial positive news that we've seen across the industry over the last few months.
Key points from report (read full report HERE):
From September To Mid-November, Execs At Four Drug Companies Involved In Operation Warp Speed Have Made Net Profit Of More Than $105M Dumping Their Companies' Stock. According to SEC filings, from the beginning of September through November 15, 2020, executives and directors at four of the companies receiving COVID vaccine funding through Operation Warp Speed have made stock transactions valued at a net profit of more than $105 million. NOTE: Johnson & Johnson did not report any new individual insider transactions during this period.
| Company | Net Profit |
| Emergent BioSolutions | $18,860,527.37 |
| Moderna | $50,406,146.77 |
| Novavax | $29,037,668.05 |
| Pfizer | $7,388,569.80 |
| Total | $105,692,911.99 |
- The net profit of transactions from May 15-November 15, 2020 was $250.9 million; the total profit of these trades was $292.1 million.
- These transactions were made by just 26 individuals, an average profit of more than $9.7 million per individual.
- Moderna remained the most active trader overall, making 491 transactions valued at a net profit of $165.9 million
- Novavax was an active trader in recent months - making 103 transactions valued at a net profit of $29 million from September 1-November 15. In contrast, from May 15 to August 31 - a period 4 weeks shorter - Novavax made 53 transactions valued at a net profit of $17.3 million.
- Novavax made the vast majority of the recent trades in a six-day period from September 26-October 1, bringing in a net profit of $26.2 million for four of its executives. Two days prior, on September 24, the company announced it was moving into Phase 3 trials for its COVID vaccine candidate
- Pfizer's CEO and EVP dumped 176,000 shares in the company at a net profit of $7.4M as stock prices surged the same day it announced positive initial trial results on its COVID vaccine candidate
- Note that these trades do not account for these executives' other, traditional compensation sources like salary, bonuses or most stock benefits.
Additional background
CNN: Pfizer and Moderna could score $32 billion in COVID-19 vaccine sales in 2021 alone: The imminent authorization of Pfizer's Covid-19 vaccine in the United States is a momentous occasion for science, the economy and humanity. The milestone is also a major moneymaker for the companies that developed the vaccines. Wall Street analysts are projecting Pfizer and Moderna will generate $32 billion in Covid-19 vaccine revenue -- next year alone..."It is absolutely wrong for drug companies like Pfizer and Moderna to profiteer, and for their executives to make egregious personal fortunes, off of Covid-19 vaccines that have been so heavily subsidized and supported by American taxpayers," said Eli Zupnick, a spokesman for Accountable.US, a progressive watchdog and patient advocacy group. [CNN, 12/11/20]
LA Times: Good vaccine news and a flurry of stock sales by executives. There's a pattern, study finds: As they raced to develop vaccines against COVID-19, executives at some pharmaceutical companies collected huge windfalls by selling stock around the time their companies announced positive news about the vaccines..The Washington, D.C.-based progressive watchdog group Accountable has also called on the SEC to investigate the Pfizer and Moderna trades. [LA Times, 12/7/20]
CBS: Watchdog urges SEC to investigate vaccine maker Moderna: An anti-corruption watchdog group is urging the U.S. Securities and Exchange Commission to investigate top executives at Moderna, the biotech firm developing a promising coronavirus vaccine, for allegedly manipulating the stock market. "This misconduct was particularly egregious because it involved not only financial fraud and manipulation of the financial markets, but also because it exploited widespread fears surrounding the ongoing COVID-19 pandemic," wrote Kyle Herrig, who heads Accountable.US, in a letter to the SEC. "I strongly urge the SEC to investigate these matters." [CBS, 6/3/20]
Reuters: Exclusive: Novavax executives could get big payday even if vaccine fails: One of the leading U.S. firms developing a coronavirus vaccine, Novavax Inc NVAX.O, has awarded executives stock options that could pay out tens of millions of dollars even if its efforts fail..."Drug companies like Novavax are getting billions of dollars from taxpayers to develop a COVID-19 vaccine, so it's certainly concerning to see their executives get massive payouts before we know if the vaccine actually works," said Eli Zupnick, a spokesman for consumer watchdog Patients Over Pharma. [Reuters, 7/22/20]
CBS: Moderna executives hiked their stock sales after announcing positive vaccine trial: Moderna CEO Stephane Bancel more than tripled the number of his company shares to be sold through an executive stock plan that was changed just days after the biotech in May announced positive early results for its coronavirus vaccine. ...the fact that the plans were changed during the pandemic as news was emerging about the company's closely watched coronavirus vaccine raises new questions about how Moderna executives have pocketed millions of dollars in recent months. "Once again, drug company executives have been caught playing games with their stock options," Kyle Herrig, who heads the government watchdog group Accountable.US, said in an email to CBS MoneyWatch.The group last month urged the SEC to investigate top executives at Moderna for allegedly manipulating the stock market. "The SEC needs to investigate these stock-plan changes," Herrig said. [CBS, 7/21/20]
Salon: Pharma execs dumped millions in stock for huge profits after getting pandemic contracts: Pharmaceutical executives continued to dump millions of dollars in stock in August despite criticism that they were profiting from big taxpayer-funded contracts awarded amid the coronavirus pandemic. Stock prices have soared for pharmaceutical companies like Moderna, which is developing a leading vaccine candidate, in no small part thanks to contracts awarded by the Trump administration. The top five executives at Moderna sold more than $89 million in stock in the first five months of the year, with about three times as many stock transactions as in all of 2019, according to Stat News...."It certainly doesn't inspire much confidence to see drug company executives feverishly dumping their stock options and cashing out fortunes for themselves after stock prices were inflated by the billions of dollars the Trump administration shoveled into drug company coffers," Eli Zupnick, a spokesman for the progressive watchdog group Accountable Pharma, told Salon. [Salon, 8/27/20]
Accountable.US is a nonpartisan watchdog that exposes corruption in public life and holds government officials and corporate special interests accountable by bringing their influence and misconduct to light. In doing so, we make way for policies that advance the interests of all Americans, not just the rich and powerful.
LATEST NEWS
New Jersey Governor Signs Freedom to Read Act Barring Book Bans
The law, said the Democrat, "cements New Jersey's role on the forefront of preventing book bans and protecting the intellectual freedom of our educators and students."
Dec 09, 2024
Democratic New Jersey Gov. Phil Murphy on Monday signed legislation protecting librarians and prohibiting public schools and libraries from banning books—a move that came as Republican state lawmakers are proscribing a record number of titles, many of them works addressing sexual orientation, gender identity, and racial injustice.
Flanked by educators, librarians, and other advocates, Murphy signed
A.3446/S.2421—known as the Freedom to Read Act—in the Princeton Public Library.
"The Freedom to Read Act cements New Jersey's role on the forefront of preventing book bans and protecting the intellectual freedom of our educators and students," said Murphy. "Across the nation, we have seen attempts to suppress and censor the stories and experiences of others. I'm proud to amplify the voices of our past and present, as there is no better way for our children to prepare for the future than to read freely."
According to a statement from Murphy's office:
Under the law, boards of education and governing boards of public libraries are barred from excluding books because of the origin, background, or views of the material or of its authors. Further, boards of education and governing boards of public libraries are prevented from censoring library material based on a disagreement with a viewpoint, idea, or concept, or solely because an individual finds certain content offensive, unless they are restricting access to developmentally inappropriate material for certain age groups.
The legislation "also provides protections for library staff members against civil and criminal lawsuits related to complying with this law."
New Jersey Association of School Librarians President Karen Grant said that "the Freedom to Read Act recognizes the professionalism, honor, work ethics, and performance of school and public library staff" and "promotes libraries as trusted sources of information and recognizes the many roles that libraries play in students' lives."
"The bill will protect the intellectual freedom of students as well as acknowledge that school libraries are centers for voluntary inquiry, fostering students' growth and development," Grant added. "Additionally, we are grateful for the broad coalition of support from so many organizations for this legislation."
The leader of one of those groups—Garden State Equality executive director Christian Fuscarino—said, "Gov. Murphy just made it clear: In New Jersey, censorship loses, and freedom wins."
"At a time when access to diverse and inclusive materials is under attack across the nation, this legislation sends a powerful message that New Jersey will stand firm in protecting intellectual freedom and fostering a culture of understanding and inclusion," Fuscarino added.
The New Jersey law comes amid a near-tripling in the number of books banned or challenged by Republican state lawmakers and right-wing organizations over the past year, with PEN America counting over 10,000 such titles during the 2023-24 academic year—up from 3,362 titles during the previous scholastic year.
With Murphy's signature, New Jersey joins Minnesota and Illinois in passing state legislation to counter GOP book-banning efforts.
As the Chicago Tribunereported Sunday, "a number of school districts, many of them in deeply conservative areas of south and central Illinois," are giving up state grants rather than adopting principles against book-banning."Keep ReadingShow Less
'Completely Un-American': Progressives Slam Trump Plan to End Birthright Citizenship
"Emboldened by a Supreme Court that would use its power to uphold white supremacy rather than the constitution of our nation, Trump is on a mission to weaken the very soul of our nation," said Rep. Delia Ramirez.
Dec 09, 2024
Progressives in Congress and other migrant rights advocates sharply criticized U.S. President-elect Donald Trump for his comments on immigration during a Sunday interview, including on his hopes to end birthright citizenship.
During a 76-minute interview with NBC News' Kristen Welker, Trump said he "absolutely" intends to end birthright citizenship, potentially through executive order, despite the 14th Amendment to the U.S. Constitution. Among many lies the Republican told, he also falsely claimed that the United States is the only country to offer citizenship by birth; in fact, there are dozens.
In response,
outgoing Congressional Progressive Caucus Chair Pramila Jayapal (D-Wash.) said on social media Monday: "This is completely un-American. The 14th Amendment guarantees birthright citizenship. Trump cannot unilaterally end it, and any attempt to do so would be both unconstitutional and immoral."
Congresswoman Gwen Moore (D-Wis.) similarly stressed that "birthright citizenship is enshrined in the Constitution as a cornerstone of American ideals. It reflects our belief that America is the land of opportunity. Sadly, this is just another in the long line of Trump's assault on the U.S. Constitution."
Rep. Delia Ramirez (D-Ill.), the daughter of Guatemalan immigrants, said in a statement: "'Give me your tired, your poor, your huddled masses yearning to breathe free.' It is important to remember who we are, where many of us came from, and why many of our families traveled here to be greeted by the Mother of Exiles, the Statue of Liberty."
Ramirez argued that "the story of our nation wouldn't be complete without the sweat, tears, joy, dreams, and hopes of so many children of immigrants who are citizens by birthright and pride themselves on being AMERICANS. It is the story of so many IL-03 communities, strengthened by the immigration of people from Poland, Ukraine, Italy, Mexico, and Guatemala, among others. It is the story of many members of Congress who can point to the citizenship of their forebears and ancestors because of immigration and birthright."
"Let's be clear: Trump is posing the question of who gets to be an American to our nation. And given that today's migrants are from Africa, Asia, the Caribbean, and Latin and Central America, it is clear he is questioning who are the 'right' people to benefit from birthright citizenship," she continued. "Questioning birthright citizenship is anti-American, and eliminating it through executive action is unconstitutional. Donald Trump knows that."
"But emboldened by a Supreme Court that would use its power to uphold white supremacy rather than the Constitution of our nation, Trump is on a mission to weaken the very soul of our nation," she warned. "I—like many sons and daughters of immigrants and first-generation Americans—believe in and fight for a land of freedom, opportunities, and equality. To live into that promise, we must stand against white nationalism—especially when it is espoused at the highest levels of government."
Although Republicans are set to control both the U.S. Senate and the House of Representatives next year, amending the Constitution requires support from two-thirds of both chambers of Congress and three-fourths of the state legislatures, meaning that process is unlikely to be attempted for this policy.
Rep. Adriano Espaillat (D-N.Y.) highlighted the difficulties of passing constitutional amendments while discussing Trump in a Monday appearance on CNN. The incoming chair of the Congressional Hispanic Caucus was born in the Dominican Republic and is the first formerly undocumented immigrant elected to Congress.
As Mother Jones reporter Isabela Dias detailed Monday:
Critics of ending birthright citizenship for the U.S.-born children of undocumented immigrants argue it would not only constitute bad policy, but also a betrayal of American values and, as one scholar put it to me, a "prelude" to mass deportation.
"It's really 100 years of accepted interpretation," Hiroshi Motomura, a scholar of immigration and citizenship at UCLA's law school, told me of birthright citizenship. Ending birthright citizenship would cut at the core of the hard-fought assurance of equal treatment under the law, he said, "basically drawing a line between two kinds of American citizens."
Trump's NBC interview also addressed his long-promised mass deportations. The president-elect—whose first administration was globally condemned for separating migrant families at the southern border and second administration is already filling up with hard-liners—suggested Sunday that he would deport children who are U.S. citizens with undocumented parents.
"I don't want to be breaking up families, so the only way you don't break up the family is you keep them together and you have to send them all back," Trump told Welker.
Responding in a Monday statement, America's Voice executive director Vanessa Cárdenas said, "There's a growing consensus that the Trump mass deportation agenda will hit American consumers and industries hard, but the scope of what Trump and his team are proposing goes well beyond the economic impact."
"Trump and allies are making clear their mass deportation agenda will include deporting U.S. citizens, including children, while aiming to gut a century and a half of legal and moral precedent on birthright citizenship," she added. "In total, their attacks go well beyond the narrow lens of immigration to the fundamental question of who gets to be an American."
Keep ReadingShow Less
Green, Indigenous Groups Warns Arctic Still at Grave Drilling Risk When Trump Returns
"Drilling for oil in the Arctic National Wildlife Refuge is all risk with no reward," said one advocate.
Dec 09, 2024
Wildlife protection groups and Indigenous leaders in Alaska said Monday that they would push to discourage bidding in an oil and gas lease sale just announced by the U.S. Interior Department for part of the Arctc National Wildlife Refuge.
Under the 2017 Tax Cuts and Jobs Act, which opened the refuge for oil and gas drilling, the Biden administration announced the second of two lease sales, set to be held on January 9, 2025.
The first Trump administration held the initial lease sale in 2021, but with banks and insurance companies increasingly reticent to back drilling projects in the area, it generated little interest and led to less than 1% of the projected sale revenue.
Releasing its final record of decision, the Interior Department said Monday that 400,000 acres of wilderness in the refuge's 1.6-million-acre northwest Coastal Plain would be put up for bidding at a minimum price of $30 per acre—despite vocal opposition from the Gwich'in Nation and the Iñupiat Alaska Natives.
The land supports local communities as well as porcupine caribou herds and polar bears.
"Our way of life, our food security, and our spiritual well-being is directly tied to the health of the caribou and the health of this irreplaceable landscape," Kristen Moreland, executive director of Gwich'in Steering Committee, toldBloomberg News. "Every oil company stayed away from the first lease sale, and we expect them to do the same during the second."
The record of decision concludes the Bureau of Land Management's process for developing a supplemental environmental impact statement, which was required after President-elect Donald Trump's first administration completed an analysis with "fundamental flaws and legal errors," as the Sierra Club said Monday.
Selling the drilling rights just before Trump takes office could complicate the GOP's plans to hold a more expansive sale later on, but Dan Ritzman, director of Sierra Club's Conservation Campaign, emphasized that regardless of who is in office when the sale takes place, "oil and gas development in the Arctic Refuge is a direct threat to some of the last untouched landscapes on Alaska's North Slope and to the caribou herds that the Gwich'in people rely on."
"The 2017 tax act, forced through Congress by Donald Trump and his Big Oil CEO allies, opened up the Coastal Plain to oil and gas leasing," said Ritzman. "Letting him oversee a lease sale over these pristine lands would be beyond irresponsible. In the meantime, President [Joe] Biden should listen to the Gwich'in and do all that he can to preserve these lands and waters. His legacy is on the line."
Erik Grafe, an attorney at environmental law firm Earthjustice, said the group is "committed to going to court as often as necessary to defend the Arctic Refuge from oil drilling and will work toward a more sustainable future that does not depend on ever-expanding oil extraction."
"Drilling for oil in the Arctic National Wildlife Refuge is all risk with no reward," said Grafe. "Oil drilling would destroy this beautiful land, held sacred by Gwich'in people, and would further destabilize the global climate, but it offers zero benefit to taxpayers or consumers."
Defenders of Wildlife called on Congress to repeal the 2017 tax law's mandate for leasing sales in the "iconic American landscape" of the Arctic Refuge.
"Turning the coastal plain into an oilfield will obliterate the pristine wilderness of the Arctic Refuge," said Nicole Whittington-Evans, Alaska senior program director for the group, "directly threatening the future of the Porcupine caribou herd and the physical, cultural, and spiritual existence of the Gwich'in people who depend on them."
Keep ReadingShow Less
Most Popular